|
SYT11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33159999973864E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15589999996713E-06 |
| Normal-vs-Stage2 |
3.039700E-02 |
| Normal-vs-Stage3 |
2.323500E-03 |
| Normal-vs-Stage4 |
3.256300E-02 |
| Stage1-vs-Stage2 |
6.237000E-01 |
| Stage1-vs-Stage3 |
1.597020E-01 |
| Stage1-vs-Stage4 |
2.452800E-01 |
| Stage2-vs-Stage3 |
2.891400E-01 |
| Stage2-vs-Stage4 |
2.958200E-01 |
| Stage3-vs-Stage4 |
9.363800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.71620000053186E-07 |
| Normal-vs-AfricanAmerican |
3.788500E-02 |
| Normal-vs-Asian |
4.841000E-03 |
| Caucasian-vs-AfricanAmerican |
8.773000E-01 |
| Caucasian-vs-Asian |
6.541400E-01 |
| AfricanAmerican-vs-Asian |
6.537400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.057060E-03 |
| Normal-vs-Female |
6.46309999963179E-07 |
| Male-vs-Female |
2.604800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.10159999999293E-05 |
| Normal-vs-Age(41-60Yrs) |
1.378560E-04 |
| Normal-vs-Age(61-80Yrs) |
8.783300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.072200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.599200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.223400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.008400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.943800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.232400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.247400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.433700E-02 |
| Classical-VS-Follicular |
2.09960000496778E-08 |
| Classical-VS-Other |
4.135400E-03 |
| Classical-VS-Normal |
1.14550002816571E-09 |
| Tall-VS-Follicular |
4.601700E-02 |
| Tall-VS-Other |
7.264400E-02 |
| Tall-VS-Normal |
5.091800E-02 |
| Follicular-VS-Other |
3.333800E-01 |
| Follicular-VS-Normal |
9.814600E-01 |
| Other-VS-Normal |
1.583240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.035600E-04 |
| Normal-vs-N1 |
1.941560E-01 |
| N0-vs-N1 |
2.406100E-02 |
|
|
